100
Participants
Start Date
February 28, 2015
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Phenylephrine
one of six initial treatments Phenylephrine Hydrochloride Injection (PHI) will be initially administered to approximately 50 subjects as an intravenous bolus (IV-B) at Low (1 μg/kg), Med (3 μg/kg), or High (5 μg/kg) level; PHI will be initially administered to approximately 50 subjects as a continuous intravenous infusion (IV-I) at Low (0.25 μg/kg/min), Med (0.75 μg/kg/min), or High (1.25 μg/kg/min) level\]; each initial treatment group will have two PK sampling schedules.
TERMINATED
Stony Brook Medicine, Stony Brook
WITHDRAWN
Alfred I. DuPont Hospital for Children, Wilmington
TERMINATED
Children's National Medical Center, Washington D.C.
TERMINATED
Ruby Memorial Hospital, Morgantown
TERMINATED
University of Mississippi Medical Center, Jackson
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Children's Medical Center of Dallas, Dallas
WITHDRAWN
Seattle Children's Hospital, Seattle
RECRUITING
Jackson Memorial Hospital, Miami
TERMINATED
Children's Healthcare of Atlanta at Egleston, Atlanta
West-Ward Pharmaceutical
INDUSTRY